[HTML][HTML] Inflammatory and molecular pathways in heart failure—ischemia, HFpEF and transthyretin cardiac amyloidosis

D Michels da Silva, H Langer, T Graf - International journal of molecular …, 2019 - mdpi.com
Elevated pro-inflammatory biomarkers and cytokines are associated with morbidity and
mortality in heart failure (HF). Preclinical and clinical studies have shown multiple …

NLRP3 inflammasome in acute myocardial infarction

AG Mauro, A Bonaventura, E Mezzaroma… - Journal of …, 2019 - journals.lww.com
Acute myocardial infarction (AMI) is associated with the induction of a sterile inflammatory
response that leads to further injury. The NACHT, leucine-rich repeat, and pyrin domain …

[HTML][HTML] P2X3 receptor antagonism attenuates the progression of heart failure

RM Lataro, DJA Moraes, FN Gava, ACM Omoto… - Nature …, 2023 - nature.com
Despite advances in the treatment of heart failure, prognosis is poor, mortality high and there
remains no cure. Heart failure is associated with reduced cardiac pump function, autonomic …

[HTML][HTML] What is the role of the inflammation in the pathogenesis of heart failure?

EC Castillo, E Vázquez-Garza, D Yee-Trejo… - Current Cardiology …, 2020 - Springer
Abstract Purpose of Review In heart failure, whether it is associated with reduced or
preserved ejection fraction, the immune system is activated and contributes to heart …

Pathogenic pathways and therapeutic targets of inflammation in heart diseases: A focus on Interleukin‐1

MG Del Buono, A Bonaventura… - European Journal of …, 2024 - Wiley Online Library
Background An exuberant and dysregulated inflammatory response contributes to the
development and progression of cardiovascular diseases (CVDs). Methods This narrative …

Immunomodulatory interventions in myocardial infarction and heart failure: a systematic review of clinical trials and meta-analysis of IL-1 inhibition

M Panahi, A Papanikolaou, A Torabi… - Cardiovascular …, 2018 - academic.oup.com
Following a myocardial infarction (MI), the immune system helps to repair ischaemic
damage and restore tissue integrity, but excessive inflammation has been implicated in …

[HTML][HTML] Emerging roles of inflammasomes in cardiovascular diseases

Y Liao, K Liu, L Zhu - Frontiers in Immunology, 2022 - frontiersin.org
Cardiovascular diseases are known as the leading cause of morbidity and mortality
worldwide. As an innate immune signaling complex, inflammasomes can be activated by …

[HTML][HTML] Molecular basis of inflammation in the pathogenesis of cardiomyopathies

E Monda, G Palmiero, M Rubino, F Verrillo… - International Journal of …, 2020 - mdpi.com
Cardiomyopathies (CMPs) represent a diverse group of heart muscle diseases, grouped into
specific morphological and functional phenotypes. CMPs are associated with mutations in …

[HTML][HTML] Translational overview of cytokine inhibition in acute myocardial infarction and chronic heart failure

MHT Hartman, HE Groot, IM Leach, JC Karper… - Trends in cardiovascular …, 2018 - Elsevier
Many cytokines are currently under investigation as potential target to improve cardiac
function and outcome in the setting of acute myocardial infarction (MI) or chronic heart failure …

IL-1 blockade reduces inflammation in pulmonary arterial hypertension and right ventricular failure: a single-arm, open-label, phase IB/II pilot study

CR Trankle, JM Canada, D Kadariya… - American journal of …, 2019 - atsjournals.org
Over time, patients with longstanding pulmonary arterial hypertension (PAH) experience
pressure overload in the right ventricle (RV), leading to reduced contractile force and …